ISSN 2149-2263 | E-ISSN 2149-2271
pdf
Myocardial Repolarization and Drugs - Impossibility to predict the dominance of anti-arrythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling [Anatol J Cardiol]
Anatol J Cardiol. 2001; 1(1): 27-34

Myocardial Repolarization and Drugs - Impossibility to predict the dominance of anti-arrythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling

Harry J.G.M. Crijins1, Marc A. Vos2
1Department of Cardiology, Academic Hospitol Maastrich & Cardivascular Research, Academic Hospital Groningen, the Netherlands
2Department of Cardiology, Academic Hospitol Maastrich & Cardivascular Research Institute Maastricht, The Netherlands

It is known that application of anti-arrhythmic drugs for the acute treatment of arrhythmic can not only result in succesfull termination or prevention, but also can lead to unwanted pro- arrhythmic effects. On the basis of two arrhythmias, atrial fibrilation and Torsade de Pointes arrhythmias, we will highlight the relevance of differential atrial and ventricular electrical remodeling to explain the delicate and dynamic balance between anti- arrhythmic efficacy and pro- arrhythmogenic consequences of class III anti- arrhythmic drugs.


Harry J.G.M. Crijins, Marc A. Vos. Myocardial Repolarization and Drugs - Impossibility to predict the dominance of anti-arrythmic over pro-arrhythmic effects of drugs due to differential and ventricular electrical remodeling. Anatol J Cardiol. 2001; 1(1): 27-34
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.